ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.930
+0.010 (0.52%)
At close: Aug 22, 2025, 4:00 PM
1.910
-0.020 (-1.02%)
After-hours: Aug 22, 2025, 7:59 PM EDT

ESSA Pharma Statistics

Total Valuation

ESSA Pharma has a market cap or net worth of $91.31 million. The enterprise value is -$18.31 million.

Market Cap91.31M
Enterprise Value -18.31M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

ESSA Pharma has 47.31 million shares outstanding. The number of shares has increased by 0.40% in one year.

Current Share Class 47.31M
Shares Outstanding 47.31M
Shares Change (YoY) +0.40%
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.08%
Owned by Institutions (%) 40.41%
Float 33.36M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.79
P/TBV Ratio 0.84
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 69.07

Current Ratio 69.07
Quick Ratio 68.84
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -21.25% and return on invested capital (ROIC) is -15.57%.

Return on Equity (ROE) -21.25%
Return on Assets (ROA) -15.25%
Return on Invested Capital (ROIC) -15.57%
Return on Capital Employed (ROCE) -27.23%
Revenue Per Employee n/a
Profits Per Employee -$721,863
Employee Count35
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.26% in the last 52 weeks. The beta is 1.56, so ESSA Pharma's price volatility has been higher than the market average.

Beta (5Y) 1.56
52-Week Price Change -64.26%
50-Day Moving Average 1.82
200-Day Moving Average 1.73
Relative Strength Index (RSI) 65.50
Average Volume (20 Days) 474,565

Short Selling Information

Short Interest 770,433
Short Previous Month 685,653
Short % of Shares Out 2.23%
Short % of Float n/a
Short Ratio (days to cover) 1.82

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -29.66M
Pretax Income -27.67M
Net Income -25.27M
EBITDA n/a
EBIT -29.66M
Earnings Per Share (EPS) -$0.57
Full Income Statement

Balance Sheet

The company has $109.62 million in cash and n/a in debt, giving a net cash position of $109.62 million or $2.32 per share.

Cash & Cash Equivalents 109.62M
Total Debt n/a
Net Cash 109.62M
Net Cash Per Share $2.32
Equity (Book Value) 108.90M
Book Value Per Share 2.45
Working Capital 108.90M
Full Balance Sheet

Cash Flow

Operating Cash Flow -20.88M
Capital Expenditures n/a
Free Cash Flow -20.88M
FCF Per Share -$0.44
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ESSA Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.40%
Shareholder Yield -0.40%
Earnings Yield -27.67%
FCF Yield -22.87%

Analyst Forecast

The average price target for ESSA Pharma is $2.00, which is 3.63% higher than the current price. The consensus rating is "Hold".

Price Target $2.00
Price Target Difference 3.63%
Analyst Consensus Hold
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 25, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date Apr 25, 2018
Split Type Reverse
Split Ratio 1:20

Scores

Altman Z-Score n/a
Piotroski F-Score 2